Migdal Insurance & Financial Holdings Ltd. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Migdal Insurance & Financial Holdings Ltd. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$9,083
+25.7%
648,302
-7.2%
0.19%
+16.2%
Q2 2023$7,227
+12.0%
698,3020.0%0.17%
+16.8%
Q1 2023$6,452
+4.2%
698,3020.0%0.14%
+3.6%
Q4 2022$6,194
-99.9%
698,3020.0%0.14%
+5.3%
Q3 2022$5,810,000
+1.6%
698,3020.0%0.13%
+3.1%
Q2 2022$5,719,000
-6.0%
698,3020.0%0.13%
+19.8%
Q1 2022$6,082,000
-8.4%
698,3020.0%0.11%
+65.6%
Q4 2021$6,641,000
-43.5%
698,3020.0%0.06%
-48.4%
Q3 2021$11,745,000
+10.1%
698,3020.0%0.12%
+10.7%
Q2 2021$10,663,000
-21.6%
698,3020.0%0.11%
-18.2%
Q1 2021$13,603,000
+2.2%
698,302
-5.4%
0.14%
-12.7%
Q4 2020$13,304,000
-6.6%
738,3020.0%0.16%
-20.7%
Q3 2020$14,242,000
-26.1%
738,3020.0%0.20%
-36.7%
Q2 2020$19,284,000
+46.4%
738,3020.0%0.31%
+2.3%
Q1 2020$13,171,000
-46.5%
738,3020.0%0.31%
-35.6%
Q4 2019$24,637,000
+33.7%
738,302
-4.5%
0.48%
+24.3%
Q3 2019$18,428,000
+45.1%
773,302
+118.9%
0.38%
+17.5%
Q2 2019$12,698,000
-2.7%
353,3020.0%0.32%
+4.2%
Q1 2019$13,051,000353,3020.31%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2020
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders